Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Optimizing antiplatelet therapy in ACS: a network meta-analysis of simplified regimens

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Novel antiplatelet approaches following acute coronary syndromes or percutaneous coronary intervention

Access
Like
Thumbnail

Cardiovascular prevention with GLP1 agonists in high or very-high cardiovascular risk irrespective of diabetes.

Event: ESC Congress 2024

Topic: Secondary Prevention

Session: Obesity and pre-diabetes: where do we stand today on prevention and treatment?

Access
Like
Thumbnail

Heart failure and renal outcomes in patient treated with GLP1 agonists.

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Biomarkers to guide the treatment of heart failure: where are we going?

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources